Slide 1: Preliminary Second Quarter 2024 Revenue and Select Financial Results
Preliminary Second Quarter 2024 Revenue and Select Financial Results July 9, 2024
Slide 2: Safe Harbor Statement
2 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of federal securities laws, including, among others, statements about our expectations, plans, strategies or prospects. We generally use the words “may,” “will,” “expect,” “believe,” “anticipate,” “plan,
Slide 3: Preliminary Results | Second Quarter 2024
3 • Consolidated revenue is expected to be approximately $496 million, including Healthcare revenues of approximately $344 million and Non-Healthcare revenues of approximately $152 million. • Healthcare revenue growth is expected to be 22% on a reported basis and 23% on a constant currency basis(1).
Slide 4: Preliminary Results | Year-to-Date Through the Second Quarter 2024
4 • Consolidated revenue is expected to be approximately $989 million, including Healthcare revenues of approximately $683 million and Non-Healthcare revenues of approximately $306 million. • Healthcare revenue growth is expected to be 9% on both a reported and constant currency basis(1). o Consumab
Slide 5: Key Performance Indicators (KPI) Professional Healthcare
Driver Installed Base # of Units (MM) Total Consumable & Service Revenue $MM, shown at constant currency(2) Consumable & Service Revenue Per Driver Annualized Revenue $ per Driver(3) Key Performance Indicators (KPI) Professional Healthcare | Year-to-Date Through the Second Quarter 1.55 1.65 1.78 2.0
Slide 6: Consumable Revenue by Technology Platform
SET Pulse Oximetry | Consumable Revenue Shown at constant currency(1) Rainbow & Hemodynamics | Consumable Revenue Shown at constant currency(1) Capnography & Gas Monitoring | Consumable Revenue Shown at constant currency(1) Brain Monitoring | Consumable Revenue Shown at constant currency(1) Consumab
Slide 7: Appendix
¥ Masimo Appendix
Slide 8: Quarterly Performance and Q3 2024 Guidance
(Unaudited; in millions, except percentages) (1,2) Quarterly Performance Year-To-Date Q3 2024 Guidance (2) Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 YTD 2023 YTD 2024 Revenue Healthcare 347 281 308 340 340 344 628 683 Non-Healthcare 218 174 171 209 153 152 393 306 GAAP revenue $565 $455 $479 $